证券记录 · 已归档季度
JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
21被追踪持有人
n/aΔ持有人
161.11M持有股份
$23.53B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 12.70M | $3.29B | n/a | −2 |
| Q2 2026 | 181 | +1 | 1.42B | $361.32B | +5 | −5 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | n/a | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | n/a |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | n/a | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | n/a |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | n/a | −2 |
| Q2 2024 | 21 | n/a | 161.11M | $23.53B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 55.10M | n/a | $8.03B | 0.7% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (被动) | 29.09M | n/a | $4.25B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 24.91M | n/a | $3.64B | 0.4% | n/c | 1 | SEC ↗ ×2 |
| 4 | Wellington Management ✦ | 24.85M | n/a | $3.63B | 0.7% | n/c | 1 | SEC ↗ ×7 |
| 5 | Fisher Asset Management ✦ | 7.01M | n/a | $1.02B | 0.4% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 3.88M | n/a | $567.83M | 0.8% | n/c | 1 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 3.35M | n/a | $489.18M | 0.8% | n/c | 1 | SEC ↗ ×5 |
| 8 | Bridgewater Associates ✦ | 3.20M | n/a | $468.34M | 2.4% | n/c | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 1.53M | n/a | $223.58M | 0.4% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.46M | n/a | $212.68M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 1.16M | n/a | $170.12M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 12 | Tweedy, Browne ✦ | 1.13M | n/a | $165.23M | 7.6% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.08M | n/a | $157.41M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 852.52K | n/a | $124.60M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 828.12K | n/a | $121.04M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 649.75K | n/a | $94.97M | 0.2% | n/c | 1 | SEC ↗ |
| 17 | Markel Group ✦ | 610.80K | n/a | $89.27M | 0.9% | n/c | 1 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 218.02K | n/a | $31.87M | 0.4% | n/c | 1 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 98.36K | n/a | $14.38M | 0.2% | n/c | 1 | SEC ↗ |
| 20 | Fairfax Financial ✦ | 73.40K | n/a | $10.72M | 0.9% | n/c | 1 | SEC ↗ |
| 21 | Dodge & Cox ✦ | 21.10K | n/a | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 136.10K 股份, $33,268 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Schmid Timothy
Officer · 11.07K 股 · $3.04M
Sep 02
Schmid Timothy
Officer · 22.53K 股 · $6.19M
Aug 17
Taubert Jennifer L
Officer · 15.00K 股 · $3.95M
Aug 13
Duato Joaquin
Officer, Director · 102.31K 股 · $26.70M
Aug 13
Duato Joaquin
Officer, Director · 20.98K 股 · $5.50M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据